About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

UPDATED: Walmart Axes Half the Drug Brands Covered in Employee Health Benefit Plan

By Jim Edwards | Jul 20, 2009

Walmart today axed half the branded drugs it covers in an employee health benefit plan, according to a letter leaked to BNET.

  • UPDATE: Walmart confirmed the move. See the official statement below.

Previously, Walmart’s health benefits covered about 260 brand name drugs — from Abilify to Zyprexa – according to a Walmart “Quick Reference Preferred Brand List” from January 2009. The July 20, 2009, list contains only about 128 preferred brands.

The move has huge consequences for workers’ health — Walmart is the U.S.’s largest employer with about 1.1 million employees (or “associates,” as the company calls them). Roughly 700,000 associates are covered by the health plan, a Walmart spokesperson said.

The pharmaceutical industry will also cringe at the news, as Walmart’s pharmacy benefit manager, WellPoint, will no longer pay for dozens of blockbuster or niche brands.

Among those affected in the shuffle: Sanofi-Aventis’ Ambien CR is axed but Sepracor’s Lunesta stays on the list. Shire’s Adderall XR loses its place but Bristol-Myers Squibb’s Abilify stays on. The moves will likely push more Walmart workers to rely on the company’s $4 generic drug program, in which anyone can pay cash at the retail giant’s pharmacies for older drug equivalents that are off-patent.

A letter sent to Walmart employees states:

Effective July 20, 2009, the Preferred and Non-Preferred Brand Name Drug programs will be eliminated and will be replaced with a singe [sic] Brand Name Drug Plan. All of the drugs covered under the Non-Preferred Brand Name Drug Program will be eliminated (except Specialty Drugs).

Important changes to your Pharmacy benefits include: … A single Brand Name Drug benefit with a cost to you of $30 or 20 percent, whichever is greater. (Any Brand prescription drug not on the Brand Name Drug List will not be covered.)

We are committed to helping you save money and live a better life.

A Walmart spokesperson told BNET that an associate could save $300 a year by switching from the $30 copay for a branded drug to Walmart’s $4 generics. Walmart’s Greg Rossiter tolf BNET:

We’re in the midst of communicating this. It doesn’t take effect until next month [because some employees did not yet get the letter]. We’re pushing back the effective date to August 10.

Some Walmart employees are, unsurprisingly, unhappy. One told BNET:

There are no generics for drugs like Arthrotec that has protection for the stomach, and Ambien CR that is time released to help you sleep entirely through the night.

… Our insurance costs over $300 a month.

Walmart’s official statement on the cuts, from Rossiter:

Walmart is well-known for providing associates with affordable prescription drugs, including more than 2,000 generic drugs available to associates at a cost of $4.  Recently, Walmart began informing our associates that we will simplify the company’s pharmacy benefits.  Beginning August 10, the company will consolidate three drug benefits into two:  a “Brand Name Drug benefit” and a generic drug program.

In many cases, our associates could see savings by converting a single prescription to a generic drug of $300 a year. Associates that choose to continue to take prescriptions that are not included in the Brand Name Drug or generic drug benefit will pay the regular retail price and receive the associate discount averaging about 20 percent. The current coverage program for specialty drugs, such as those that treat specific chronic or genetic conditions, isn’t affected.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Wal-Mart cuts branded formulary in half

    FiercePharma - 203 days 18 hours 37 minutes ago

    Wal-Mart slashed its employee drug benefits in half, cutting the number of branded meds on its formulary to 128 from 260, BNet Pharma reports. Big-time drugs like Sanofi-Aventis' Ambien CR and Shire's Adderall XR won't be paid for by the company plan anymore. According to a letter Wal-Mart sent to its workers, the company is going from a...

  • Wal-Mart's wearing a new hat: health care advocate

    Health Populi - 357 days 19 hours 28 minutes ago

    Nearly 100% of Wal-Mart's staff is covered by health insurance, either through the company itself or through another source. Covered "associates" reached a total of 94.5% this month , compared with 92.7% last year. The total proportion of Wal-Mart employees covered by Wal-Mart's plans at the end of open enrollment was 51.8%. Uninsured Wal-Mart...

  • Marketing Daily: Wal-Mart Credits Ads With Leap In Awareness

    MediaPost - 357 days 11 hours 27 minutes ago

    While lawsuit settlements and currency fluctuations caused a profit decline for the quarter, Wal-Mart Stores turned in better-than-expected results for the full fiscal year, with sales climbing 7.2% to $401 billion in sales. And the company says an increase in fourth-quarter ad spending paid off--with U.S. consumer awareness of its "Save money,...

  • Financial incentives promote engagment in health, EBRI finds - but who's engaged?

    Health Populi - 67 days 21 hours ago

    The fifth annual survey on consumer engagement in health care from the Employee Benefit Research Institute (EBRI) finds that members of consumer-driven health plans (CDHPs) are more cost-conscious than enrollees in traditional health plans. These members also tend to be more engaged in wellness and health promotion programs. Health...

  • Americans' demand for generic drugs is up

    Health Populi - 378 days 12 hours 33 minutes ago

    4 in 5 Americans would choose generic drugs over brand name drugs, according to The Harris Poll conducted among American adults in December 2008. In Substantial Increase in Public Preference for Generic over Brand Name Drugs , Harris found that the proportion of people who would more often pick branded drugs fell by nearly one-half, from...

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
Click Here